Skip to main content
Premium Trial:

Request an Annual Quote

Caprion's Desjardins Plans for Proteomics

Premium

Clarissa Desjardins’ serial startup career began, oddly enough, in the lab. “I made some discoveries during my PhD,” she says — she and her lab partner had discovered a particularly useful fluorescent reagent and decided to commercialize it. They founded Advanced Bioconcept Limited in 1992 and weren’t exactly prepared for what was to come: “Two recent science graduates trying to start a reagent business in peptides — it was a very big struggle,” she says.

But thanks to the addition of more experienced leadership in the form of Martin LeBlanc and Lloyd Segal by 1996, ABL turned around. “Martin really turned it into an operating company,” Desjardins says. With sales increasing by 25 percent each quarter, her board assured her that the company would become an acquisition target and advised her to “invest in some more high-risk, high-return type technologies,” she says. NEN, now part of PerkinElmer, did acquire ABL in 1998, and the day before the sale, Desjardins and her crew spun out Caprion Pharmaceuticals, which would commercialize the new prion research they had started.

Today, Desjardins, senior vice president of business development, has out-licensed the prion program, but says it laid the foundation for Caprion’s new emphasis on proteomics. “We invested in a big way last year in a proteomics platform,” she says, adding that the first task is examining drug targets for colon cancer. “The prion is the poster child of the importance of proteins as opposed to genes.”

— Meredith Salisbury

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.